UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 453

Sortiert nach

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Annals of oncology, 2020-02, Vol.31 (2), p.228-235

2020

Volltextzugriff (PDF)

Forty-one recent cases of invasive zygomycosis from a global clinical registry

Journal of antimicrobial chemotherapy, 2010-02, Vol.65 (2), p.296-302

2010

Volltextzugriff (PDF)

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors

American journal of transplantation, 2014-11, Vol.14 (11), p.2577-2587

2014

Volltextzugriff (PDF)

Use of real World evidence in German amnog applications

Value in health, 2015-05, Vol.18 (3), p.A95-A95

2015

Volltextzugriff (PDF)

Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.922-925

2013

Volltextzugriff (PDF)

Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program

Annals of oncology, 2018-06, Vol.29, p.v103-v103

2018

Volltextzugriff (PDF)

Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD

Bone marrow transplantation (Basingstoke), 2011-09, Vol.46 (9), p.1274-1275

2011

Volltextzugriff (PDF)

HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data

Value in health, 2023-12, Vol.26 (12), p.S318

2023

Volltextzugriff (PDF)

Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease

European journal of clinical nutrition, 2005-11, Vol.59 (11), p.1302-1309

2005

Volltextzugriff (PDF)

PNS169 The New Quality Requirements for Claims DATA Analyses in the German Amnog HTA Process

Value in health, 2020-12, Vol.23, p.S669-S669

2020

Volltextzugriff (PDF)

PNS150 Trends in the Relevance of Real World Evidence Studies in the German Benefit Assessment (AMNOG) Process 2011-2019

Value in health, 2020-12, Vol.23, p.S666-S666

2020

Volltextzugriff (PDF)

HTA203 Methods Used for Trend Estimation of Epidemiological Figures in the German Benefit Assessment (AMNOG) Process

Value in health, 2022-12, Vol.25 (12), p.S336-S336

2022

Volltextzugriff (PDF)

HTA92 10 Years of AMNOG: Importance of Real-World Evidence Studies in the German Benefit Assessment Process

Value in health, 2022-12, Vol.25 (12), p.S314-S314

2022

Volltextzugriff (PDF)

EPH162 Pilot Study to Assess the Prevalence of Advanced Gastrointestinal Stromal Tumor Identified Using German Claims Data

Value in health, 2022-12, Vol.25 (12), p.S222-S222

2022

Volltextzugriff (PDF)

Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain

The journal of pain, 2001-08, Vol.2 (4), p.197-204

2001

Volltextzugriff (PDF)

Bond behaviour of NSM FRP strips in service

Structural concrete : journal of the FIB, 2008-09, Vol.9 (3), p.127-142

2008

Volltextzugriff (PDF)

PNS283 STATUS QUO OF CLAIMS DATA ANALYSES IN THE GERMAN AMNOG HTA PROCESS - DID QUALITY IMPROVE?

Value in health, 2019-11, Vol.22, p.S811-S811

2019

Volltextzugriff (PDF)

Screening auf Mangelernährung erfordert ausreichende Mitarbeiterschulung

Aktuelle Ernährungsmedizin, 2012, Vol.37 (3)

2012

Volltextzugriff (PDF)

PNS204 THE RELEVANCE OF REAL WORLD EVIDENCE STUDIES IN THE GERMAN BENEFIT ASSESSMENT (AMNOG) PROCESS

Value in health, 2019-11, Vol.22, p.S795-S795

2019

Volltextzugriff (PDF)

Real World Use of Extracorporeal Photopheresis After Heart Transplantation - Clinical Outcomes from a Seven Centre European Study

The Journal of heart and lung transplantation, 2022-04, Vol.41 (4), p.S476-S477

2022

Volltextzugriff (PDF)

The Impact Of Patient Preference Studies In The German Healthcare System

Value in health, 2017-10, Vol.20 (9), p.A690

2017

Volltextzugriff (PDF)

Overcoming the Limitations of Claims Data: Linkage of Claims Data with Secondary Data Sources in Germany

Value in health, 2017-10, Vol.20 (9), p.A745

2017

Volltextzugriff (PDF)

PHP222 - The Impact Of Patient Preference Studies In The German Healthcare System

Value in health, 2017-10, Vol.20 (9), p.A690-A690

2017

Volltextzugriff (PDF)

PRM81 - Overcoming the Limitations of Claims Data: Linkage of Claims Data with Secondary Data Sources in Germany

Value in health, 2017-10, Vol.20 (9), p.A745-A745

2017

Volltextzugriff (PDF)

PUK13 - THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY – A CLAIMS DATABASE ANALYSIS

Value in health, 2018-10, Vol.21, p.S476-S477

2018

Volltextzugriff (PDF)

1 – 25 von 453

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(379)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(141)
Humans
(114)
Physical Sciences
(73)
Female
(69)
Male
(68)
Biological And Medical Sciences
(66)
Physics
(50)
Medical Sciences
(44)
Animals
(42)
Adult
(34)
Technology
(34)
Middle Aged
(32)
Child
(27)
Molecular Sequence Data
(24)
Chemistry
(23)
Biochemistry & Molecular Biology
(22)
Fundamental And Applied Biological Sciences. Psychology
(22)
Ophthalmology
(22)
Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Forty-one recent cases of invasive zygomycosis from a global clinical registry

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors

Use of real World evidence in German amnog applications

Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors

Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program

Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD

HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data

Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease

PNS169 The New Quality Requirements for Claims DATA Analyses in the German Amnog HTA Process

PNS150 Trends in the Relevance of Real World Evidence Studies in the German Benefit Assessment (AMNOG) Process 2011-2019

HTA203 Methods Used for Trend Estimation of Epidemiological Figures in the German Benefit Assessment (AMNOG) Process

HTA92 10 Years of AMNOG: Importance of Real-World Evidence Studies in the German Benefit Assessment Process

EPH162 Pilot Study to Assess the Prevalence of Advanced Gastrointestinal Stromal Tumor Identified Using German Claims Data

Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain

Bond behaviour of NSM FRP strips in service

PNS283 STATUS QUO OF CLAIMS DATA ANALYSES IN THE GERMAN AMNOG HTA PROCESS - DID QUALITY IMPROVE?

Screening auf Mangelernährung erfordert ausreichende Mitarbeiterschulung

PNS204 THE RELEVANCE OF REAL WORLD EVIDENCE STUDIES IN THE GERMAN BENEFIT ASSESSMENT (AMNOG) PROCESS

Real World Use of Extracorporeal Photopheresis After Heart Transplantation - Clinical Outcomes from a Seven Centre European Study

The Impact Of Patient Preference Studies In The German Healthcare System

Overcoming the Limitations of Claims Data: Linkage of Claims Data with Secondary Data Sources in Germany

PHP222 - The Impact Of Patient Preference Studies In The German Healthcare System

PRM81 - Overcoming the Limitations of Claims Data: Linkage of Claims Data with Secondary Data Sources in Germany

PUK13 - THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY – A CLAIMS DATABASE ANALYSIS

Suchergebnisse filtern